Microfluidic Blood Separation: Key Technologies and Critical Figures of Merit

Published

November 18, 2023

Author(s)

Karina Torres Castro, Katherine Acuña-Umaña, Leonardo Lesser-Rojas, Darwin Reyes-Hernandez

Abstract

Blood is a complex sample comprised mostly of plasma, red blood cells (RBCs), and other cells whose concentrations correlate to physiological or pathological health conditions. There are also many blood-circulating biomarkers, such as circulating tumor cells (CTCs) and various pathogens, that can be used as measurands to diagnose certain diseases. Microfluidic devices are attractive analytical tools for separating blood components in point-of-care (POC) applications. These platforms have the potential advantage of, among other features, being compact and portable. These features can eventually be exploited in clinics and rapid tests performed in households and low-income scenarios. Microfluidic systems have the added benefit of only needing small volumes of blood drawn from patients (from nanoliters to milliliters) while integrating (within the devices) the steps required before detecting analytes. Hence, these systems will reduce the associated costs of purifying blood components of interest (e.g., specific groups of cells or blood biomarkers) for studying and quantifying collected blood fractions. The microfluidic blood separation field has grown since the 2000s, and important advances have been reported in the last few years. Nonetheless, real POC microfluidic blood separation platforms are still elusive. A widespread consensus on what key figures of merit should be reported to assess the quality and yield of these platforms has not been achieved. Knowing what parameters should be reported for microfluidic blood separations will help achieve that consensus and establish a clear road map to promote further commercialization of these devices and attain real POC applications. This review provides an overview of the separation techniques currently used to separate blood components for higher throughput separations (number of cells or particles per minute). We present a summary of the critical parameters that should be considered when designing such devices and the figures of merit that should be explicitly reported when presenting a device's separation capabilities. Ultimately, reporting the relevant figures of merit will benefit this growing community and help pave the road toward commercialization of these microfluidic systems.

Citation

Micromachines

Volume

14

Issue

11

Pub Type

Journals

Download Paper

https://doi.org/10.3390/mi14112117

Local Download

Keywords

Separation of blood, Blood sorting, microfluidic separations, blood contents, sorting, RBC, blood contents, lab-on-a-chip, microfluidics, pathogenic bacteria

Citation

Torres Castro, K. , Acuña-Umaña, K. , Lesser-Rojas, L. and Reyes-Hernandez, D. (2023), Microfluidic Blood Separation: Key Technologies and Critical Figures of Merit, Micromachines, [online], https://doi.org/10.3390/mi14112117, https://tsapps.nist.gov/publication/get_pdf.cfm?pub_id=936235 (Accessed March 13, 2025)